Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer

Year in Review: Clinical Investigator Perspec...

Research To PracticeResearch To Practice

Up next

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics:Introduction (0:00)Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging Utility of Circulating Tumor DNA Evalua ...  Show more

 . 49min 29sec
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

Featuring perspectives from Dr Neeraj Agarwal, Dr Elisabeth I Heath, Dr Daniel P Petrylak, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Heath, including the following topics:Introduction (0:00)Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr ...  Show more

 . 1h 58min

Recommended Episodes

18F-PSMA-1007 PET/CT - Sponsored by Mayo Clinic
Radiology Podcast | RSNA

Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detectio ...  Show more

 . 18min 6sec
Professor Joël Guigay on clinical trials of older patients with head and neck cancer
The Lancet Healthy Longevity in conversation with

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles: https://www.thelancet.com/ ...  Show more

 . 34min 38sec
AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis
AUANews Inside Tract

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ...  Show more

 . 51min 37sec
A Reassessment of Prostate Cancer Treatment (Live from the 2024 ASCO Annual Meeting)
Symptomatic: A Medical Mystery Podcast

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care.  Dr. Mohammad Atiq shares ways innovative treatments are paving the ...  Show more

 . 41min 41sec